Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1978 1
1979 3
1980 2
1981 1
1982 1
1983 4
1984 2
1985 3
1986 3
1987 6
1988 4
1989 4
1990 12
1991 4
1992 13
1993 10
1994 6
1995 9
1996 17
1997 11
1998 13
1999 16
2000 11
2001 30
2002 26
2003 21
2004 18
2005 25
2006 28
2007 26
2008 32
2009 27
2010 33
2011 47
2012 45
2013 53
2014 55
2015 68
2016 59
2017 58
2018 39
2019 41
2020 56
2021 52
2022 52
2023 47
2024 25

Text availability

Article attribute

Article type

Publication date

Search Results

995 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Differentiated Thyroid Gland Carcinoma"
Page 1
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. Haugen BR, et al. Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020. Thyroid. 2016. PMID: 26462967 Free PMC article. Review.
BACKGROUND: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. ...Recommendations related to long-term management of differentiated thyroid cancer include those related to surveil …
BACKGROUND: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly p …
Thyroid Cancer: A Review.
Boucai L, Zafereo M, Cabanillas ME. Boucai L, et al. JAMA. 2024 Feb 6;331(5):425-435. doi: 10.1001/jama.2023.26348. JAMA. 2024. PMID: 38319329 Review.
Papillary, follicular (4%), and oncocytic (2%) forms arise from thyroid follicular cells and are termed well-differentiated thyroid cancer. Aggressive forms of follicular cell-derived thyroid cancer are poorly differentiated thyroid …
Papillary, follicular (4%), and oncocytic (2%) forms arise from thyroid follicular cells and are termed well-differentiated …
Radioiodine therapy in advanced differentiated thyroid cancer: Resistance and overcoming strategy.
Liu Y, Wang J, Hu X, Pan Z, Xu T, Xu J, Jiang L, Huang P, Zhang Y, Ge M. Liu Y, et al. Drug Resist Updat. 2023 May;68:100939. doi: 10.1016/j.drup.2023.100939. Epub 2023 Feb 8. Drug Resist Updat. 2023. PMID: 36806005 Free article. Review.
Differentiated thyroid cancer (DTC) is the most common pathological subtype which is typically curable with surgery and Radioactive iodine (RAI) therapy (approximately 85%). Radioactive iodine is the first-line treatment for patients with metastatic Papillary …
Differentiated thyroid cancer (DTC) is the most common pathological subtype which is typically curable with surgery and Radioa …
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.
Dierks C, Seufert J, Aumann K, Ruf J, Klein C, Kiefer S, Rassner M, Boerries M, Zielke A, la Rosee P, Meyer PT, Kroiss M, Weißenberger C, Schumacher T, Metzger P, Weiss H, Smaxwil C, Laubner K, Duyster J, von Bubnoff N, Miething C, Thomusch O. Dierks C, et al. Thyroid. 2021 Jul;31(7):1076-1085. doi: 10.1089/thy.2020.0322. Epub 2021 Apr 15. Thyroid. 2021. PMID: 33509020 Free PMC article.
Background: Anaplastic thyroid carcinoma (ATC) and metastatic poorly differentiated thyroid carcinomas (PDTCs) are rare aggressive malignancies with poor overall survival (OS) despite extensive multimodal therapy. ...The combination treatment is …
Background: Anaplastic thyroid carcinoma (ATC) and metastatic poorly differentiated thyroid carcinomas (P …
Follicular thyroid carcinoma.
Sobrinho-Simões M, Eloy C, Magalhães J, Lobo C, Amaro T. Sobrinho-Simões M, et al. Mod Pathol. 2011 Apr;24 Suppl 2:S10-8. doi: 10.1038/modpathol.2010.133. Mod Pathol. 2011. PMID: 21455197 Free article. Review.
Follicular thyroid carcinoma is being diagnosed less and less frequently despite the increasing incidence of well-differentiated thyroid carcinomas everywhere. ...It will address the differential diagnosis between follicular carcinoma and …
Follicular thyroid carcinoma is being diagnosed less and less frequently despite the increasing incidence of well-different …
Genomic and Transcriptomic Characteristics of Metastatic Thyroid Cancers with Exceptional Responses to Radioactive Iodine Therapy.
Boucai L, Saqcena M, Kuo F, Grewal RK, Socci N, Knauf JA, Krishnamoorthy GP, Ryder M, Ho AL, Ghossein RA, Morris LGT, Seshan V, Fagin JA. Boucai L, et al. Clin Cancer Res. 2023 Apr 14;29(8):1620-1630. doi: 10.1158/1078-0432.CCR-22-2882. Clin Cancer Res. 2023. PMID: 36780190 Free PMC article.
We aimed to identify genomic and transcriptomic factors associated with structural responses to RAI treatment of metastatic thyroid cancer, which occur infrequently, and to test whether high MAPK pathway output was associated with RAI refractoriness. ...Molecular pr …
We aimed to identify genomic and transcriptomic factors associated with structural responses to RAI treatment of metastatic thyroi …
Immunohistochemical Biomarkers in Thyroid Pathology.
Baloch Z, Mete O, Asa SL. Baloch Z, et al. Endocr Pathol. 2018 Jun;29(2):91-112. doi: 10.1007/s12022-018-9532-9. Endocr Pathol. 2018. PMID: 29744727 Review.
Immunohistochemical markers are used to confirm that an unusual tumor in the thyroid is indeed of thyroid origin, either of follicular epithelial or C-cell differentiation; the various mimics include nonthyroidal lesions such as parathyroid tumors, par …
Immunohistochemical markers are used to confirm that an unusual tumor in the thyroid is indeed of thyroid origin, either of fo …
Applications of Immunohistochemistry to Endocrine Pathology.
Higgins SE, Barletta JA. Higgins SE, et al. Adv Anat Pathol. 2018 Nov;25(6):413-429. doi: 10.1097/PAP.0000000000000209. Adv Anat Pathol. 2018. PMID: 30157042 Review.
The role of immunohistochemistry (IHC) in endocrine pathology is similar to that in other organ systems in that it can aid in the subclassification of tumors within an organ, confirm site of primary in metastatic disease, provide prognostic information, identify underlying …
The role of immunohistochemistry (IHC) in endocrine pathology is similar to that in other organ systems in that it can aid in the subclassif …
Application of Immunohistochemistry in Papillary Thyroid Carcinoma.
Lam AK, Lee KT. Lam AK, et al. Methods Mol Biol. 2022;2534:175-195. doi: 10.1007/978-1-0716-2505-7_13. Methods Mol Biol. 2022. PMID: 35670976
The major diagnostic applications of IHC include confirmation of papillary thyroid carcinoma in sites other than the thyroid, distinguish papillary thyroid carcinoma from other primary thyroid neoplasms in thyroid, and ident …
The major diagnostic applications of IHC include confirmation of papillary thyroid carcinoma in sites other than the thyroi …
Differentiated thyroid cancer.
Kumar A, Bal CS. Kumar A, et al. Indian J Pediatr. 2003 Sep;70(9):707-13. doi: 10.1007/BF02724312. Indian J Pediatr. 2003. PMID: 14620185
OBJECTIVE: The retrospective analysis of the case files of children with differentiated thyroid carcinoma (DTC) was performed to define the disease by its presentation, clinical course and outcome of radioiodine therapy. ...CONCLUSION: Differentiated …
OBJECTIVE: The retrospective analysis of the case files of children with differentiated thyroid carcinoma (DTC) was per …
995 results